Your browser doesn't support javascript.
Letter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
Saad, Mohamed O.
  • Saad MO; Department of Pharmacy, Al-Wakra Hospital, Hamad Medical Corporation, PO Box 82228 Doha, Qatar. Electronic address: msaad4@hamad.qa.
Int J Antimicrob Agents ; 57(1): 106171, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1065123
Semantic information from SemMedBD (by NLM)
1. hydroxychloroquine TREATS COVID-19
Subject
hydroxychloroquine
Predicate
TREATS
Object
COVID-19
2. azithromycin TREATS COVID-19
Subject
azithromycin
Predicate
TREATS
Object
COVID-19
3. hydroxychloroquine TREATS COVID-19
Subject
hydroxychloroquine
Predicate
TREATS
Object
COVID-19
4. azithromycin TREATS COVID-19
Subject
azithromycin
Predicate
TREATS
Object
COVID-19

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Azithromycin / SARS-CoV-2 / COVID-19 / Hydroxychloroquine Type of study: Controlled clinical trial / Randomized controlled trials Limits: Humans Language: English Journal: Int J Antimicrob Agents Year: 2021 Document Type: Article

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Azithromycin / SARS-CoV-2 / COVID-19 / Hydroxychloroquine Type of study: Controlled clinical trial / Randomized controlled trials Limits: Humans Language: English Journal: Int J Antimicrob Agents Year: 2021 Document Type: Article